Response to Harrison et al. ‘Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'

por Gisslinger, H, Jeryczynski, G, Wölfler, A, Beham-Schmid, C, Thiele, J
Publicado 2017

First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience

por Jeryczynski, G., Antlanger, M., Duca, F., Binder-Rodriguez, C., Reiter, T., Simonitsch-Klupp, I., Bonderman, D., Kain, R., Krauth, M.-T., Agis, H.
Publicado 2021

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

por Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J
Publicado 2016

Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

por Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J
Publicado 2017

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

por Tefferi, A, Rumi, E, Finazzi, G, Gisslinger, H, Vannucchi, A M, Rodeghiero, F, Randi, M L, Vaidya, R, Cazzola, M, Rambaldi, A, Gisslinger, B, Pieri, L, Ruggeri, M, Bertozzi, I, Sulai, N H, Casetti, I, Carobbio, A, Jeryczynski, G, Larson, D R, Müllauer, L, Pardanani, A, Thiele, J, Passamonti, F, Barbui, T
Publicado 2013